Prognostic Value of Functional Assessment of Cancer Therapy-General (FACT-G) in Advanced Non-Small-Cell Lung Cancer Treated with Korean Medicine
Joint Authors
Shim, Bum Sang
Jeon, Hyeonjin
Eo, Wankyu
Kim, Sehyun
Lee, Sookyung
Source
Evidence-Based Complementary and Alternative Medicine
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-8, 8 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-01-20
Country of Publication
Egypt
No. of Pages
8
Main Subjects
Abstract EN
Objectives.
The impact of health-related quality of life (HRQoL) on survival has been investigated in patients with various cancers.
Here, we evaluated the prognostic value of HRQoL using the Functional Assessment of Cancer Therapy-General (FACT-G) in advanced non-small-cell lung cancer (NSCLC) patients treated with Korean medicine.
Methods.
A retrospective review of medical records and FACT-G scores of patients with advanced NSCLC who received treatment with Korean medicine was conducted.
The reliability of the FACT-G was determined using Cronbach’s alpha and calculating floor-and-ceiling effects.
Correlations between FACT-G scores were estimated using Pearson’s correlation analysis.
Overall survival was calculated using the Kaplan–Meier method, and the prognostic impact of FACT-G scores and patients’ characteristics was evaluated with Cox proportional hazards regression.
Results.
Of the 165 enrolled patients, 115 (70%) had extrathoracic metastasis and 139 (84%) had undergone prior anticancer treatment.
The median overall survival was 10.1 months.
The mean FACT-G score was 65.0, and Cronbach’s alpha for the FACT-G was 0.917.
Age ≥65 years, male sex, smoking history, squamous-cell carcinoma, Eastern Cooperative Oncology Group Performance Status (ECOG-PS) ≥2, and presence of extrathoracic metastasis were associated with an increased risk of mortality.
High FACT-G total scores, physical well-being (PWB), emotional well-being, and functional well-being were associated with prolonged survival.
After adjusting for age, sex, smoking history, ECOG-PS, histological type, and presence of extrathoracic metastasis, a high FACT-G total score (hazard ratio (HR): 0.99, p=0.032) and high PWB score (HR: 0.94, p<0.001) were associated with prolonged survival as independent prognostic factors in patients with advanced NSCLC.
Conclusion.
The FACT-G total score and PWB score as HRQoL measurements were significant prognostic factors for survival in advanced NSCLC patients treated with Korean medicine.
This finding implies that the FACT-G can be used in clinical practice as a predictor of survival in patients with advanced NSCLC.
American Psychological Association (APA)
Jeon, Hyeonjin& Eo, Wankyu& Shim, Bum Sang& Kim, Sehyun& Lee, Sookyung. 2020. Prognostic Value of Functional Assessment of Cancer Therapy-General (FACT-G) in Advanced Non-Small-Cell Lung Cancer Treated with Korean Medicine. Evidence-Based Complementary and Alternative Medicine،Vol. 2020, no. 2020, pp.1-8.
https://search.emarefa.net/detail/BIM-1155447
Modern Language Association (MLA)
Jeon, Hyeonjin…[et al.]. Prognostic Value of Functional Assessment of Cancer Therapy-General (FACT-G) in Advanced Non-Small-Cell Lung Cancer Treated with Korean Medicine. Evidence-Based Complementary and Alternative Medicine No. 2020 (2020), pp.1-8.
https://search.emarefa.net/detail/BIM-1155447
American Medical Association (AMA)
Jeon, Hyeonjin& Eo, Wankyu& Shim, Bum Sang& Kim, Sehyun& Lee, Sookyung. Prognostic Value of Functional Assessment of Cancer Therapy-General (FACT-G) in Advanced Non-Small-Cell Lung Cancer Treated with Korean Medicine. Evidence-Based Complementary and Alternative Medicine. 2020. Vol. 2020, no. 2020, pp.1-8.
https://search.emarefa.net/detail/BIM-1155447
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1155447